Emma Ann Coleman, DO | |
4300 B St Ste 200, Anchorage, AK 99503-5933 | |
(907) 375-3361 | |
(907) 375-3351 |
Full Name | Emma Ann Coleman |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 9 Years |
Location | 4300 B St Ste 200, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780078758 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 132777 (Alaska) | Primary |
207R00000X | Internal Medicine | 132777 (Alaska) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Alaska Native Medical Center | Anchorage, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alaska Native Tribal Health Consortium | 6709780265 | 466 |
Southcentral Foundation | 5496663627 | 120 |
News Archive
This year's Eastern Pain Society Scientific meeting was held at Mount Sinai Beth Israel Medical Center in New York City in late October and is one of the largest meetings of pain physicians and fellows in the tri-state area.
A collaboration between scientists in Trinity College Dublin and the United Kingdom has identified new processes that lead to the development of a novel cell implicated in allergies. The discovery has the potential for new strategies to treat asthma and other allergic diseases.
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a developer of an ophthalmological therapeutic sustained-release drug delivery platform.
At the forefront of technological advancement, Omnicell UK & Ireland, has launched a new automated pharmacy packaging and filling solution which will help community pharmacy to drive efficiencies in the face of major funding cuts. The Omnicell VBM 200F will help to reinforce the company's reputation as a world-leading provider of automated healthcare solutions and medication adherence packaging.
› Verified 7 days ago
Entity Name | Alaska Native Tribal Health Consortium |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
This year's Eastern Pain Society Scientific meeting was held at Mount Sinai Beth Israel Medical Center in New York City in late October and is one of the largest meetings of pain physicians and fellows in the tri-state area.
A collaboration between scientists in Trinity College Dublin and the United Kingdom has identified new processes that lead to the development of a novel cell implicated in allergies. The discovery has the potential for new strategies to treat asthma and other allergic diseases.
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a developer of an ophthalmological therapeutic sustained-release drug delivery platform.
At the forefront of technological advancement, Omnicell UK & Ireland, has launched a new automated pharmacy packaging and filling solution which will help community pharmacy to drive efficiencies in the face of major funding cuts. The Omnicell VBM 200F will help to reinforce the company's reputation as a world-leading provider of automated healthcare solutions and medication adherence packaging.
› Verified 7 days ago
Entity Name | Southcentral Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
This year's Eastern Pain Society Scientific meeting was held at Mount Sinai Beth Israel Medical Center in New York City in late October and is one of the largest meetings of pain physicians and fellows in the tri-state area.
A collaboration between scientists in Trinity College Dublin and the United Kingdom has identified new processes that lead to the development of a novel cell implicated in allergies. The discovery has the potential for new strategies to treat asthma and other allergic diseases.
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a developer of an ophthalmological therapeutic sustained-release drug delivery platform.
At the forefront of technological advancement, Omnicell UK & Ireland, has launched a new automated pharmacy packaging and filling solution which will help community pharmacy to drive efficiencies in the face of major funding cuts. The Omnicell VBM 200F will help to reinforce the company's reputation as a world-leading provider of automated healthcare solutions and medication adherence packaging.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Emma Ann Coleman, DO 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: () - | Emma Ann Coleman, DO 4300 B St Ste 200, Anchorage, AK 99503-5933 Ph: (907) 375-3361 |
News Archive
This year's Eastern Pain Society Scientific meeting was held at Mount Sinai Beth Israel Medical Center in New York City in late October and is one of the largest meetings of pain physicians and fellows in the tri-state area.
A collaboration between scientists in Trinity College Dublin and the United Kingdom has identified new processes that lead to the development of a novel cell implicated in allergies. The discovery has the potential for new strategies to treat asthma and other allergic diseases.
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a developer of an ophthalmological therapeutic sustained-release drug delivery platform.
At the forefront of technological advancement, Omnicell UK & Ireland, has launched a new automated pharmacy packaging and filling solution which will help community pharmacy to drive efficiencies in the face of major funding cuts. The Omnicell VBM 200F will help to reinforce the company's reputation as a world-leading provider of automated healthcare solutions and medication adherence packaging.
› Verified 7 days ago
Casey Mapes, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Stephen C Ellison, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Jonathan Daining, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Dr. Heath Wade Turner, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Alisha Alexandra Skinner, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3355 | |
Esther Lee Hargrave, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Larry Scott Owen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 |